Keros Therapeutics, Inc. (KROS)
Sale of 551 shares at $10.30 per share.
Reporting Person Newton Charles W. · Transaction Code S
Traded Aug 18, 2026 · Disclosed Aug 20, 2026
Source: SEC Form 4 · 0001866219-26-000010 · filed 2026-08-20 · View filing →
Company
KROS · CIK 0001664710
Sale of 551 shares at $10.30 per share.
Reporting Person Newton Charles W. · Transaction Code S
Traded Aug 18, 2026 · Disclosed Aug 20, 2026
Source: SEC Form 4 · 0001866219-26-000010 · filed 2026-08-20 · View filing →
Sale of 3,568 shares at $10.29 per share.
Reporting Person Lerner Lorena Raquel · Officer Title Chief Scientific Officer · Transaction Code S
Traded Aug 18, 2026 · Disclosed Aug 20, 2026
Source: SEC Form 4 · 0002081359-26-000008 · filed 2026-08-20 · View filing →
Sale of 4,485 shares at $10.29 per share.
Reporting Person Cho Esther · Officer Title Chief Legal Officer · Transaction Code S
Traded Aug 18, 2026 · Disclosed Aug 20, 2026
Source: SEC Form 4 · 0002081460-26-000009 · filed 2026-08-20 · View filing →
Sale of 1,224 shares at $10.29 per share.
Reporting Person Tanini Annita · Officer Title Corp. Controller & VP, Finance · Transaction Code S
Traded Aug 18, 2026 · Disclosed Aug 20, 2026
Source: SEC Form 4 · 0002146784-26-000004 · filed 2026-08-20 · View filing →
Purchase of 1,000 shares at $10.27 per share.
Reporting Person BIENAIME JEAN JACQUES · Transaction Code P
Traded Aug 17, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001221590-26-000025 · filed 2026-08-19 · View filing →